Table 1.
Summary of the studies discussed in the text.
LV Main Applications in GBM Research | References |
---|---|
Basic Studies | |
Dissecting the tumor biology | [10,11,12,13,14,18,19,23,26,27,28,29,30,31] |
Identification of novel therapeutic targets | [15,16,17,20,21,22,24,25] |
LV as Tools for Gene and Cell Therapy of GBM | |
Gene Therapy | |
Gene therapy approaches based on transgene expression | [37,38,39,55,56] |
Gene therapy approaches based on silencing/gene editing | [46,47,50,51,53,54] |
Gene Therapy approaches aimed at overcoming GMB resistance to therapy | [57,58,59,60,61,62,63,64,68] |
Immunotherapy of GBM via LV expressing CARs | [72,73,74,75,76] |
Cell Therapy | |
LV transduced cells as carriers of therapeutic molecules | [82,83,84,85,86,87,88,90,91] |
LV to Create Animal Models | |
Murine models | [97,98,99,100,101,102,103,104] |
Non-murine models | [93,94,95,96,105] |
LV: Last-generation lentiviruses; GBM: Glioblastoma; CAR: chimeric antigen receptors.